Last reviewed · How we verify
NCT05579158
Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial
NA trial testing Mobile application and wearable device in Non-Alcoholic Fatty Liver Disease in 337 participants. Completed in 12 January 2024.
12 January 2024
Quick facts
| Lead sponsor | Hanyang University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 337 |
| Start date | 1 February 2023 |
| Primary completion | 12 January 2024 |
| Estimated completion | 12 January 2024 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Mobile application and wearable device
- Time-restricted eating
Conditions studied
- Non-Alcoholic Fatty Liver Disease — all drugs for Non-Alcoholic Fatty Liver Disease →
- Time Restricted Feeding — all drugs for Time Restricted Feeding →
- Mobile Technology — all drugs for Mobile Technology →
Sponsor
Hanyang University
Who can join
19 and older, any sex, with Non-Alcoholic Fatty Liver Disease or Time Restricted Feeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In non-alcoholic fatty liver disease (NAFLD), it is established that calorie restriction is the most essential dietary modification. The time-restricted diet is successful lowering total calorie consumption and insulin resistance, and is anticipated to be beneficial for patients with NAFLD. Therefore, this study aims to conduct a prospective study to determine the effect of time-restricted diet via a mobile application on the amount of intrahepatic fat and 10-year cardiovascular disease risk in patients with NAFLD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05579158
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Non-Alcoholic Fatty Liver Disease
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07294963 — Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease · NA · recruiting
- NCT07130318 — Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise · NA · recruiting
- NCT06355310 — Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease · Phase 2 · recruiting
- NCT06863376 — Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients · Phase 2 · recruiting
Other Hanyang University trials
Trials by the same sponsor.
- NCT06230302 — Efficacy and Safety of Kefir Whey Postbiotics · NA · unknown
- NCT06812091 — Human Microbiome Research and Development for Overcoming Pediatric Diseases · recruiting
- NCT04449224 — Comparative Effectiveness of Targeted Therapy in RA Patients · unknown
- NCT03983408 — Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease · NA · unknown
- NCT03438903 — Comparison of Repeatability Between SS and SD-OCT for Measuring Retinal Thickness in Various Retinal Diseases · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05579158 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hanyang University
- Last refreshed: 24 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05579158.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing